{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:38:55Z","timestamp":1789133935307,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI059884"],"award-info":[{"award-number":["AI059884"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI065200"],"award-info":[{"award-number":["AI065200"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001873"],"award-info":[{"award-number":["UL1TR001873"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116208","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T01:22:28Z","timestamp":1632100948000},"page":"116208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Bone and fat hormonal crosstalk with antiretroviral initiation"],"prefix":"10.1016","volume":"154","author":[{"given":"Arnold Z.","family":"Olali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Bucovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Shane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116208_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115509","article-title":"Deficits in bone strength, density and microarchitecture in women living with HIV: A cross-sectional HR-pQCT study","volume":"138","author":"Macdonald","year":"2020","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2021.116208_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230368","article-title":"Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: a five-year prospective study","volume":"15","author":"Han","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bone.2021.116208_bb0015","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jbmr.3183","article-title":"Immediate initiation of antiretroviral therapy for HIV infection accelerates bone loss relative to deferring therapy: findings from the START bone mineral density substudy, a randomized trial","volume":"32","author":"Hoy","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.116208_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jbm4.10055","article-title":"The hidden burden of fractures in people living with HIV","volume":"2","author":"Premaor","year":"2018","journal-title":"JBMR Plus"},{"issue":"4","key":"10.1016\/j.bone.2021.116208_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/hiv.12294","article-title":"Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study","volume":"17","author":"Achhra","year":"2016","journal-title":"HIV Med."},{"key":"10.1016\/j.bone.2021.116208_bb0030","doi-asserted-by":"crossref","unstructured":"Stanley, T.L. and S.K. Grinspoon, Body composition and metabolic changes in HIV-infected patients. J. Infect. Dis., 2012. 205 Suppl 3(Suppl 3): p. S383\u201390.","DOI":"10.1093\/infdis\/jis205"},{"issue":"5","key":"10.1016\/j.bone.2021.116208_bb0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molmed.2010.03.002","article-title":"HIV-associated lipodystrophy: from fat injury to premature aging","volume":"16","author":"Caron-Debarle","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bone.2021.116208_bb0040","doi-asserted-by":"crossref","unstructured":"Bares, S.H., et al., HIV-infected women gain more weight than HIV-infected men following the initiation of antiretroviral therapy. J. Women's Health (2002), 2018. 27(9): p. 1162\u20131169.","DOI":"10.1089\/jwh.2017.6717"},{"key":"10.1016\/j.bone.2021.116208_bb0045","doi-asserted-by":"crossref","unstructured":"Sharma, A., et al., Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study. J. Acquir. Immune Defic. Syndr. (1999), 2012. 61(4): p. 469\u2013476.","DOI":"10.1097\/QAI.0b013e31826cba6c"},{"key":"10.1016\/j.bone.2021.116208_bb0050","doi-asserted-by":"crossref","unstructured":"Bonnet, E., et al., Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study. BMC Infect. Dis., 2013. 13: p. 293\u20132334\u201313\u2013293.","DOI":"10.1186\/1471-2334-13-293"},{"key":"10.1016\/j.bone.2021.116208_bb0055","series-title":"Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines","author":"Kirk","year":"2020"},{"issue":"5","key":"10.1016\/j.bone.2021.116208_bb0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4158\/EP12141.RA","article-title":"Bone as an endocrine organ","volume":"18","author":"Guntur","year":"2012","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.bone.2021.116208_bb0065","doi-asserted-by":"crossref","unstructured":"Patti, A., et al., Endocrine actions of osteocalcin. Int. J. Endocrinol., 2013. 2013: p. 846480.","DOI":"10.1155\/2013\/846480"},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2265.2011.04133.x","article-title":"Regulation of glucose metabolism and the skeleton","volume":"75","author":"Ng","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2021.116208_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2017.11.020","article-title":"Osteocalcin improves insulin resistance and inflammation in obese mice: participation of white adipose tissue and bone","volume":"115","author":"Guedes","year":"2018","journal-title":"Bone"},{"issue":"13","key":"10.1016\/j.bone.2021.116208_bb0080","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-10-0414","article-title":"Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels","volume":"163","author":"Yeap","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2021.116208_bb0090","doi-asserted-by":"crossref","unstructured":"Saleem, U., T.H. Mosley, Jr., and I.J. Kullo, Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol., 2010. 30(7): p. 1474\u20131478.","DOI":"10.1161\/ATVBAHA.110.204859"},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0095","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/jcp.25976","article-title":"The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis","volume":"233","author":"Fairfield","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.bone.2021.116208_bb0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2265.2011.04315.x","article-title":"Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women","volume":"76","author":"Sheng","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"10.1016\/j.bone.2021.116208_bb0110","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1210\/jc.2012-1218","article-title":"Association of circulating sclerostin levels with fat mass and metabolic disease\u2014related markers in Japanese postmenopausal women","volume":"97","author":"Urano","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.bone.2021.116208_bb0115","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00198-016-3540-8","article-title":"Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?","volume":"27","author":"Confavreux","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.bone.2021.116208_bb0120","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191261","article-title":"Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes","volume":"217","author":"Mosialou","year":"2020","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.bone.2021.116208_bb0125","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.2337\/db07-0007","article-title":"The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance","volume":"56","author":"Yan","year":"2007","journal-title":"Diabetes"},{"issue":"7645","key":"10.1016\/j.bone.2021.116208_bb0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature21697","article-title":"MC4R-dependent suppression of appetite by bone-derived lipocalin 2","volume":"543","author":"Mosialou","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bone.2021.116208_bb0135","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/infdis\/jix246","article-title":"Antiretroviral therapy containing HIV protease inhibitors enhances fracture risk by impairing osteoblast differentiation and bone quality","volume":"215","author":"Hirakawa","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.bone.2021.116208_bb0140","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jac\/dkx011","article-title":"Changes in bone turnover markers with HIV seroconversion and ART initiation","volume":"72","author":"Slama","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bone.2021.116208_bb0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jcb.10156","article-title":"Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling","volume":"85","author":"Gordeladze","year":"2002","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.2002.17.2.200","article-title":"Leptin inhibits osteoclast generation","volume":"17","author":"Holloway","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116208_bb0160","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/jcem.87.3.8313","article-title":"Serum leptin level is a predictor of bone mineral density in postmenopausal women","volume":"87","author":"Blain","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S8756-3282(01)00487-2","article-title":"Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women","volume":"29","author":"Thomas","year":"2001","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2021.116208_bb0170","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/en.2008-1639","article-title":"In vitro and in vivo effects of adiponectin on bone","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0175","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","article-title":"Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast","volume":"331","author":"Oshima","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexcr.2005.05.021","article-title":"Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway","volume":"309","author":"Luo","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.bone.2021.116208_bb0185","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/jbmr.361","article-title":"Adipokines and the risk of fracture in older adults","volume":"26","author":"Barbour","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.116208_bb0190","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.metabol.2008.12.009","article-title":"Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women","volume":"58","author":"J\u00fcrim\u00e4e","year":"2009","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.bone.2021.116208_bb0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S8756-3282(03)00237-0","article-title":"Adiponectin as a novel determinant of bone mineral density and visceral fat","volume":"33","author":"Lenchik","year":"2003","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2021.116208_bb0200","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1210\/jc.2006-2097","article-title":"Serum adiponectin and bone mineral density in women","volume":"92","author":"Richards","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2021.116208_bb0205","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00125-005-0085-3","article-title":"In treatment-na\u00efve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100","volume":"vol. 49","author":"Das","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2021.116208_bb0210","series-title":"Adiponectin and leptin levels in Chinese patients with HIV-related lipodystrophy: a 30-month prospective study","first-page":"1265","volume":"vol. 25(12)","author":"Luo","year":"2009"},{"issue":"3","key":"10.1016\/j.bone.2021.116208_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAD.0000000000002430","article-title":"Serum extracellular vesicles expressing bone activity markers associate with bone loss after HIV antiretroviral therapy","volume":"34","author":"Marques de Menezes","year":"2020","journal-title":"Aids"},{"issue":"8","key":"10.1016\/j.bone.2021.116208_bb0220","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/infdis\/jiv194","article-title":"Changes in bone mineral density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate\/emtricitabine plus atazanavir\/ritonavir, darunavir\/ritonavir, or raltegravir","volume":"212","author":"Brown","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bone.2021.116208_bb0225","doi-asserted-by":"crossref","unstructured":"Tebas, P., et al., Greater change in bone turnover markers for efavirenz\/emtricitabine\/tenofovir disoproxil fumarate versus dolutegravir + abacavir\/lamivudine in antiretroviral therapy-naive adults over 144 weeks. AIDS (London, England), 2015. 29(1473\u20135571 (Electronic)).","DOI":"10.1097\/QAD.0000000000000863"},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/cid\/cir324","article-title":"Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG study A5224s","volume":"53","author":"McComsey","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bone.2021.116208_bb0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11657-014-0175-2","article-title":"Body mass index is positively associated with bone mineral density in US older adults","volume":"9","author":"Lloyd","year":"2014","journal-title":"Arch. Osteoporos."},{"issue":"794","key":"10.1016\/j.bone.2021.116208_bb0240","article-title":"Osteocalcin\u2014a versatile bone-derived hormone","volume":"9","author":"Moser","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bone.2021.116208_bb0245","series-title":"J Acquir Immune Defic Syndr","first-page":"e139","article-title":"Change in circulating undercarboxylated osteocalcin (ucOCN) is associated with fat accumulation in HIV-seropositive women","volume":"86","author":"Olali","year":"2021"},{"issue":"12","key":"10.1016\/j.bone.2021.116208_bb0255","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00198-014-2808-0","article-title":"Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?","volume":"25","author":"Sapir-Koren","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0260","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","volume":"27","author":"Cejka","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.bone.2021.116208_bb0265","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif. Tissue Int."},{"issue":"7","key":"10.1016\/j.bone.2021.116208_bb0270","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2215\/CJN.09470913","article-title":"Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis","volume":"9","author":"Malluche","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.bone.2021.116208_bb0275","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1210\/jc.2014-2372","article-title":"Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients","volume":"99","author":"Ishimura","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/j.bone.2021.116208_bb0280","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0032-1312618","article-title":"High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density","volume":"44","author":"Voskaridou","year":"2012","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.bone.2021.116208_bb0285","doi-asserted-by":"crossref","first-page":"E665","DOI":"10.1210\/jc.2013-2086","article-title":"Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women","volume":"99","author":"He","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116208_bb0290","article-title":"Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus","volume":"12","author":"Ross","year":"2020","journal-title":"Bone Rep."},{"issue":"52","key":"10.1016\/j.bone.2021.116208_bb0295","doi-asserted-by":"crossref","first-page":"E11238","DOI":"10.1073\/pnas.1707876115","article-title":"Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes","volume":"114","author":"Kim","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bone.2021.116208_bb0300","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jcb.25432","article-title":"Sclerostin enhances adipocyte differentiation in 3T3-L1 cells","volume":"117","author":"Ukita","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.bone.2021.116208_bb0305","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1007\/s11695-019-03914-4","article-title":"Alterations in fat mass and bone mineral density are associated with decreased lipocalin-2 after laparoscopic sleeve gastrectomy in obese Chinese women","volume":"29","author":"Wen","year":"2019","journal-title":"Obes. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0310","doi-asserted-by":"crossref","first-page":"15932","DOI":"10.1038\/s41598-020-73068-2","article-title":"Re-evaluation of serum leptin and adiponectin concentrations normalized by body fat mass in patients with rheumatoid arthritis","volume":"10","author":"Chihara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2021.116208_bb0315","unstructured":"Calmy, A., et al., Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy. (1464\u20132662 (Print))."},{"key":"10.1016\/j.bone.2021.116208_bb0320","doi-asserted-by":"crossref","unstructured":"Cirmanov\u00e1, V., et al., The effect of leptin on bone: an evolving concept of action. Physiol. Res., 2008. 57 Suppl 1: p. S143\u201351.","DOI":"10.33549\/physiolres.931499"},{"issue":"5","key":"10.1016\/j.bone.2021.116208_bb0325","first-page":"1884","article-title":"Serum leptin levels are associated with bone mass in nonobese women1","volume":"86","author":"Pasco","year":"2001","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0330","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S8756-3282(00)00408-7","article-title":"Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women","volume":"28","author":"Martini","year":"2001","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2021.116208_bb0335","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1210\/jcem.86.11.8020","article-title":"Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men","volume":"86","author":"Sato","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0340","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00223-002-1019-4","article-title":"Leptin, body composition and bone mineral density in premenopausal women","volume":"73","author":"Blum","year":"2003","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.bone.2021.116208_bb0345","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)04915-4","article-title":"Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis","volume":"79","author":"Shaarawy","year":"2003","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.bone.2021.116208_bb0350","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1359\/jbmr.2002.17.10.1896","article-title":"Relationship of serum leptin concentration with bone mineral density in the United States population","volume":"17","author":"Ruhl","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116208_bb0355","doi-asserted-by":"crossref","unstructured":"Rao, M.N., et al., Assessing the association between leptin and bone mineral density in HIV-infected men. AIDS Res Treat, 2012. 2012: p. 103072.","DOI":"10.1155\/2012\/103072"},{"issue":"4","key":"10.1016\/j.bone.2021.116208_bb0360","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QAI.0000000000001118","article-title":"Brief report: association of adipokines with bone mineral density in HIV-infected and HIV-uninfected women","volume":"73","author":"Sharma","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.bone.2021.116208_bb0365","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","article-title":"Adiponectin regulation and function","volume":"8","author":"Fang","year":"2018","journal-title":"Compr. Physiol."},{"issue":"17","key":"10.1016\/j.bone.2021.116208_bb0370","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0b013e328315a7a5","article-title":"Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults","volume":"22","author":"Carr","year":"2008","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0375","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00126334-200405010-00017","article-title":"HIV protease inhibitors increase adiponectin levels in HIV-negative men","volume":"36","author":"Lee","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209911","article-title":"Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: a substudy of the NEAT001\/ANRS143 randomised trial","volume":"14","author":"Bernardino","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0385","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","article-title":"Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice","volume":"50","author":"Ferron","year":"2012","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2021.116208_bb0390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.bone.2021.116208_bb0395","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0000000000000616","article-title":"Weight gain and integrase inhibitors","volume":"33","author":"Eckard","year":"2020","journal-title":"Curr. Opin. Infect. Dis."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:58:30Z","timestamp":1757613510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":78,"alternative-id":["S8756328221003744"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116208","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone and fat hormonal crosstalk with antiretroviral initiation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116208"}}